Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.06.16.599189

The value of initiating a pursuit in temporal decision-making

Abstract

Reward-rate maximization is a prominent normative principle commonly held in behavioral ecology, neuroscience, economics, and artificial intelligence. Here, we identify and compare equations for evaluating the worth of initiating pursuits that an agent could implement to enable reward-rate maximization. We identify two fundamental temporal decision-making categories requiring the valuation of the initiation of a pursuit--forgo and choice decision-making--over which we generalize and analyze the optimal solution for how to evaluate a pursuit in order to maximize reward rate. From this reward-rate-maximizing formulation, we derive expressions for the subjective value of a pursuit, i.e. that pursuits equivalent immediate reward magnitude, and reveal that times cost is composed of an apportionment, in addition to, an opportunity cost. By re-expressing subjective value as a temporal discounting function, we show precisely how the temporal discounting function of a reward-rate-optimal agent is sensitive not just to the properties of a considered pursuit, but to the time spent and reward acquired outside of the pursuit for every instance spent within it. In doing so, we demonstrate how the apparent discounting function of a reward-rate-optimizing agent depends on the temporal structure of the environment and is a combination of hyperbolic and linear components, whose contributions relate the apportionment and opportunity cost of time, respectively. We further then show how purported signs of suboptimal behavior (hyperbolic discounting, the Delay effect, the Magnitude effect, the Sign effect) are in fact consistent with reward-rate maximization. Having clarified what features are and are not signs of optimal decision-making, we analyze the impact of the misestimation of reward rate-maximizing parameters in order to better account for the pattern of errors actually observed in humans and animals. We find that error in agents assessment of the apportionment of time that underweights the time spent outside versus inside a considered pursuit type is the likely driver of suboptimal temporal decision-making observed behaviorally. We term this the Malapportionment Hypothesis. This generalized form for reward-rate maximization and its relation to subjective value and temporal discounting allows the true pattern of errors exhibited by humans and animals to be more deeply understood, identified, and quantified, which is key to deducing the learning algorithms and representational architectures actually used by humans and animals to evaluate the worth of pursuits.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sutlief, E., Walters, C., Marton, T., Hussain Shuler, M. G.. 2024-06-16. The value of initiating a pursuit in temporal decision-making. https://doi.org/10.1101/2024.06.16.599189

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗